Ritalin’s Risks Outweigh the Rewards… The PEA Alternative
Posted by drkaufman June 20, 2009, under Dr. Kaufman | No Comments
Dr. Richard Clark Kaufman
NEURVANA Chief Science Officer, Author, Biogerontologist
Ritalin’s connection to sudden death is only one of many problems from Ritalin stimulant therapy for ADD/ADHD.
Ritalin can disrupt growth hormone production and
ADHD appears to be associated with depressed dopamine activity in the brain
ADHD appears to be associated with depressed dopamine activity in the brain
Adults with attention-deficit/hyperactivity disorder (ADHD) show a blunted response to the drug methylphenidate (Ritalin), which increases brain dopamine levels, according to a report in the August issue of Archives
Risk takers, drug abusers driven by decreased ability to process dopamine
Posted by drkaufman June 7, 2009, under News | 2 Comments
Risk takers, drug abusers driven by decreased ability to process dopamine
For risk-takers and impulsive people, New Year’s resolutions often include being more careful, spending more frugally and cutting back on dangerous behavior, such as drug use. But new research from
